Study Finds Niacin Is Better Than Zetia At Reducing Artery Clogs

A new study published in the New England Journal of Medicine finds that Niacin (produced by Abbott and sold as Niaspan) is more effective than the new blockbuster drug ezetimibe (produced by Merck and sold as Zetia) at reducing artery-clogging deposits caused by high...